MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
10.66
+0.40 (3.90%)
Oct 13, 2025, 4:00 PM EDT - Market closed
MLTX Market Cap
MLTX has a market cap or net worth of $676.92 million as of October 13, 2025. Its market cap has decreased by -78.82% in one year.
Market Cap
676.92M
Enterprise Value
327.61M
1-Year Change
-78.82%
Ranking
Category
Stock Price
$10.66
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $676.92M, an increase of 18,713.51%. That is a compound annual growth rate of 319.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 651.52M | -80.92% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |